4.2 Article

Genetic causes of inherited retinal diseases among Israeli Jews of Ethiopian ancestry

Journal

MOLECULAR VISION
Volume 29, Issue -, Pages 1-12

Publisher

MOLECULAR VISION

Keywords

-

Ask authors/readers for more resources

This study aims to describe the phenotype frequency and genetic basis of inherited retinal diseases (IRDs) among Israeli Jewish patients of Ethiopian ancestry. The most common phenotypes observed were Stargardt disease and nonsyndromic retinitis pigmentosa, with autosomal recessive inheritance being the most common mode of inheritance. The findings of this study can assist in clinical and molecular diagnosis and potentially contribute to the development of adequate therapy in the future.
Purpose: This study sought to describe the phenotype frequency and genetic basis of inherited retinal diseases (IRDs) among a nationwide cohort of Israeli Jewish patients of Ethiopian ancestry.Methods: Patients' data-including demographic, clinical, and genetic information-were obtained through members of the Israeli Inherited Retinal Disease Consortium (IIRDC). Genetic analysis was performed by either Sanger sequencing for founder mutations or next-generation sequencing (targeted next-generation sequencing or whole-exome sequencing).Results: Forty-two patients (58% female) from 36 families were included, and their ages ranged from one year to 82 years. Their most common phenotypes were Stargardt disease (36%) and nonsyndromic retinitis pigmentosa (33%), while their most common mode of inheritance was autosomal recessive inheritance. Genetic diagnoses were ascertained for 72% of genetically analyzed patients. The most frequent gene involved was ABCA4. Overall, 16 distinct IRD mutations were identified, nine of which are novel. One of them, ABCA4-c.6077delT, is likely a founder mutation among the studied population.Conclusions: This study is the first to describe IRDs' phenotypic and molecular characteristics in the Ethiopian Jewish community. Most of the identified variants are rare. Our findings can help caregivers with clinical and molecular diagnosis and, we hope, enable adequate therapy in the near future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available